0001415889-21-003748.txt : 20210730
0001415889-21-003748.hdr.sgml : 20210730
20210730172144
ACCESSION NUMBER: 0001415889-21-003748
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210728
FILED AS OF DATE: 20210730
DATE AS OF CHANGE: 20210730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DALE MICHAEL D
CENTRAL INDEX KEY: 0001172346
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 211133555
MAIL ADDRESS:
STREET 1: 1350 ENERGY LANE SUITE 110
CITY: ST PAUL
STATE: MN
ZIP: 55108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-07302021_020718.xml
X0306
4
2021-07-28
0000001800
ABBOTT LABORATORIES
ABT
0001172346
DALE MICHAEL D
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
SENIOR VICE PRESIDENT
Common shares without par value
2021-07-28
4
M
0
17600
50.72
A
57291
D
Common shares without par value
2021-07-28
4
S
0
17600
120.3342
D
39691
D
Option (right to buy)
50.72
2021-07-28
4
M
0
17600
0
D
2020-07-21
2027-07-20
Common Shares
17600
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.3203 to $120.35, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
/s/ Michael D. Dale by Jessica H. Paik, Attorney-in-Fact
2021-07-30